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Introduction/aim Cystic lymphangioma is a benign rare
malformation of the lymphatic system consisting of
masses of abnormal lymphatic channels, occurring in one
out of 2000–4000 live births. Conventional surgical
excision remains the most popular method of treatment
in many developing countries. Recent advances in
sclerotherapy have expanded contemporary management
options, particularly when complete surgical resection is
difficult because of the presence of multiple loculi and
extensive lesions. This study aims to present our
experience in the management of these cases.
Material and methods Records of all cases of
lymphangioma seen at the Pediatric Surgical Unit from
Mansoura and Tanta University hospitals in the period from
January 2007 to November 2010 were reviewed. Special
charts were designed to retrieve the following data from
records: age at presentation, sex, site of the pathology,
clinical presentation, investigations, management modality,
and outcome of treatment.
Results There were 93 children; 40 (43%) were males and
53 (57%) were females. Surgery was the line of treatment
in 89 cases (one stage in 56 cases and two stages in
33 cases). Four patients underwent injection sclerotherapy
as the primary treatment. Recurrence occurred in 16 cases.
Other complications included a disfiguring scar in nine
patients, seroma in seven patients, skin disruption,
hematoma, and hypoglossal nerve palsy in two patients,
facial nerve palsy in one patient, and cellulitis following
a sclerosant injection in one case.
Conclusion A staged operative procedure may be
necessary in order to reduce mortality, and sclerotherapy
has almost the same efficacy as the first line of
management as surgery, although it is not widely practiced
in developing countries. There is a high postoperative
complication associated with surgical excision,
especially with head and neck cystic lymphangiomas.
Anesthesia in these patients requires careful monitoring.
Long-term follow-up is desirable after excision because of
the possibility of recurrence. Ann Pediatr Surg 8:123–128
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Introduction
Cystic lymphangioma (CL) is a benign rare malformation
of the lymphatic system [1], consisting of masses of
abnormal lymphatic channels [2], occurring in one out of
2000–4000 live births [3].
The lesion can arise anywhere, but is usually found in the
region of the neck and axillary. It may also arise from the
abdominal wall, inguinal region, buttocks, anogenital
region, and retroperitoneal areas [4]. Other rare sites
include the tongue [5], parotid [6], mediastinum [7],
spleen [8], and prostate [9]. The tissue of origin is
usually the subcutaneous tissue, but it may also arise from
muscles, bone, or rarely from internal organs [10].
CL usually presents in neonatal and infancy periods;
however, it may present in adulthood, as mesenteric and/or
retroperitoneal CL [11].
The condition presents with a soft partially compressible
swelling in the affected area, and may have a bluish hue.
Sudden enlargement may result from infections or
intracystic hemorrhage. Patients could present with
dysphagia or signs of upper airway obstruction (e.g. dys-
pnea, stridor, and cyanotic attacks), and tracheostomies
may be required. Involvement of the skin (lymphangioma
cutis) may produce puckering of the skin or vesicles that
exude a clear yellowish fluid [12].
Microscopically, CL consists of multiple loculi filled with
lymph. In the depth the loculi are quite large, but they
decrease in size toward the surface [13].
Landing and Farber [14] classified lymphangioma into
three groups: (i) lymphangioma simplex, composed of
small capillary-sized, thin-walled lymphatic channels;
(ii) cavernous lymphangioma, comprising of dilated lym-
phatic channels, often with an adventitious covering; and
(iii) CL (cystic hygroma), consisting of multiple cystic
cavities filled with a straw-colored fluid.
The terms ‘cystic hygroma’ and ‘lymphangioma’ are often
used interchangeably, and it is the most commonly
occurring lymphangioma in children [15].
Well-localized lesions are easily characterized by ultra-
sonography and computed tomography. MRI, however,
provides the most reliable diagnosis of more complex
lesions, and their macrocytic and microcytic components
or a combination thereof provide diagnostic confirmation,
delineate anatomical extension and relationship with
surrounding vital structures, and document potential
complicating factors such as an associated venous
malformation component or prominent draining blood
vessels [16–19].
Conventional surgical excision remains the most popular
method of treatment in many developing countries
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despite the dangers associated with this treatment
modality. Surgery may be multiple, complex, and may
have to be staged before complete excision can be
achieved [20].
Although complete CL excision is desired, subtotal or
partial removal may be dictated by specific organ
involvement or proximity to neurovascular structures [21]
or in cases with diffuse infiltration with an obscured
anatomy [22]. Although residual CL is left in such
circumstances, incomplete excision does not absolutely
imply recurrence requiring an additional therapeutic
intervention [23].
The surgical procedure is sometimes complex and
requires a multidisciplinary team for evaluation and
management, particularly those cases with the involv-
ement of the tongue, oral floor, and mandible [24].
The timing of surgery depends on the site of the lesion
and its potential complications. In certain instances when
lesions may potentially cause severe compression on the
airway, surgery may even be indicated during pregnancy
(ex-utero intrapartum treatment), which involves the
partial delivery of fetuses at risk for postnatal upper
airway obstruction by cesarean section and establishing
airway control while maintaining placental circulation and
oxygenation [25].
Recent advances in sclerotherapy have expanded contem-
porary management options, particularly when complete
surgical resection is difficult because of the presence of
multiple loculi and extensive lesions. Sclerotherapy pro-
vides a treatment option in such patients, offering a viable
alternative to surgery [26–29].
The popularity of sclerotherapy in the treatment of CL is
growing, and several substances are used as sclerosants.
OK-432 (a lyophilized mixture of group A Streptococcus
pyogenes and benzylpenicillin) is believed to exert its
effect by inducing endothelial damage occurring second-
ary to the activation of the host immune system [30,31].
Bleomycin exerts a mild inflammatory effect on en-
dothelial cells [32]. Other sclerosants in use are
doxycycline (a broad-spectrum antibiotic) [33], acetic
acid at a 40–50% concentration, absolute ethanol [34],
and hypertonic saline [35].
This study aims to review our experience in the
management of CL over a 3-year period in two referral
institutes.
Patients and methods
This study is a retrospective file review. The records of all
cases of lymphangioma seen at the Pediatric Surgical Unit
from in Mansoura and Tanta University hospitals in the
period from January 2007 to November 2010 were
reviewed. Special charts were designed to retrieve the
following data from the records: age at presentation, sex,
site of the pathology, clinical presentation, investigations,
management modality, and outcome of treatment.
A full informed consent was obtained from the patients’
custodians, and those who agreed to injection sclerother-
apy were injected; otherwise, surgery was performed.
The study was approved by the ethical committee in both
institutes.
Results
There were 93 children with CL within the 3-year period;
40 (43%) were males and 53 (57%) were females
(M : F = 7 : 9) ranging in age from one month to 5 years.
Their ages at presentation are shown in Table 1. Majority
(92.5%) of the patients were younger than 1 year of age.
The cervical region (Fig. 1) was the most frequent site of
involvement, followed by the axillary region (Fig. 2).
In the patients with cervical CL, the lesion was on the
left side of the neck in 20 cases. Other sites of involve-
ment were the face (Fig.3), breast (Fig.4), abdominal wall
(Fig.5), thigh (Fig. 6), mesenteric (Fig. 7), and retro-
peritoneal area (Fig. 8) (Table 2).
The diagnosis was made on the basis of the clinical
characteristics and ultrasonography. In cases with cervi-
cofacial or abdominal locations, MRI was used to
accurately characterize the swelling with respect to
extensions and in relation to nerves and major vessels.
In the seven cases with abdominal locations, six cases
presented with a palpable abdominal mass and were
further investigated by ultrasonography, computed tomo-
graphy, or MRI. In one case, CL was an incidental finding.
Antenatal detection was carried out in seven cases with a
large cervical lesion during an antenatal ultrasonographic
examination.
Table 1 Age distribution
Age N (%)
First month 47 (50.5)
> 1–3 months 16 (17.2)
> 3–6 months 13 (13.98)
> 6–12 months 10 (10.75)
> 1–5 years 7 (7.5)
Fig. 1
Cervicofacial cystic lymphangioma.
124 Annals of Pediatric Surgery 2012, Vol 8 No 4
Copyright © Annals of Pediatric Surgery. Unauthorized reproduction of this article is prohibited.
In 56 cases, the lesion was a well-localized lymphangi-
omatous malformation, and we decided on surgery to
remove the entire lesion in a single setting (Figs 9 and
10). The remaining 33 cases, however, were complex,
involving more than one anatomical region. For these
cases, a staged approach was utilized, removing as much
as possible from the lesion without injury to the
neighboring vital structures.
For lesions that involved the parotid and cervicoaxillary
regions, we used a nerve stimulator (Stimuplex DIG RC;
B. Braun Co., Melsungen, Germany) to identify the
related nerves and avoid injury to them.
All of the abdominal cases were operated by a laparo-
tomy incision; we did not use laparoscopy for any
patient.
In four cases, we used sclerosing therapy for treatment
using bleomycin injection as the primary intervention.
In another five cases, injection was used for recurrence.
Under general or local anesthesia, depending on the
patient’s age, as much cystic fluid as possible was aspirated.
After aspiration, bleomycin solution (at a concentration of
1 mg (1 U) in 1 ml normal saline solution) was injected into
the cystic lesions at a dosage of 0.3–0.6 mg/kg depending on
the size of the lesion, at a maximum dose of not more than
10 mg/injection.
The patient was hospitalized for 24 h after injection to
monitor any adverse reaction, and was then discharged to
attend an outpatient counseling after 4 weeks. A radio-
graph was ordered 6 months after injection to detect any
pulmonary complication. The results were classified as an






Abdominal wall cystic lymphangioma.
Fig. 2
Axillary cystic lymphangioma.
Management of cystic lymphangioma Hassan and Aly 125
Copyright © Annals of Pediatric Surgery. Unauthorized reproduction of this article is prohibited.
completely, as a ‘good’ response if the masses had
reduced considerably (over 50% reduction) with some
residual lesions, and as a ‘poor’ response if the masses


















Dissection of a cervical lymphangioma from neck structures.
Fig. 10
Dissection of an axillary lymphangioma from neck structures.
Fig. 6
Thigh cystic lymphangioma.
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In cases where injection was the primary line of inter-
vention, three patients showed an excellent response; all
of them required a single injection. Reduction in size
started within the first week and complete disappearance
occurred by the first month. Another patient showed a
good response. In one patient, injection was followed by
swelling and inflammation of the lesion, followed by
cellulitis. Immediate antibiotic therapy was initiated, but
the case was lost to follow-up.
In five recurrent patients who were injected, a good
response was achieved in two patients, whereas the other
three patients were re-operated for complete excision.
The injected patients developed some minor side effects
including local swelling, redness, pain, and low-grade
fever during the first 24, which required only sympto-
matic treatment. No patient developed pulmonary
interstitial fibrosis.
Sixteen patients developed recurrences (Fig. 11), includ-
ing seven patients who previously had cervical CL, four
patients who previously had axillary CL, three patients
who previously had parotid CL, one patient who
previously had abdominal CL, and one patient who
previously had thigh CL (Table 3).
Complications included recurrence in 16 patients, a
disfiguring scar in nine patients, seroma in seven patients,
skin disruption, hematoma, and hypoglossal nerve palsy in
two patients, facial nerve palsy in one patient, and
cellulitis following a sclerosant injection in one patient.
Discussion
The development of the lymphatic system can be
explained by two theories: the centripetal and centrifugal
theories. Lewis [36] supported the centrifugal theory,
and, according to this hypothesis, the lymphatic system
develops as mesenchymal spaces that later coalesce into a
system of vessels that eventually join the venous system.
Huntington and McClure supported the centripetal
theory, which proposes that the jugular and posterior
lymphatics form as outgrowths of endothelium from veins
into the surrounding mesenchyme [36].
This study showed that CL occurs more commonly in the
cervicoaxillary region compared with other regions of the
body. This distribution pattern is similar to that reported
by other studies [8,15,20].
Most patients (92.5%) presented before the age 1 year.
Late presentation (after the neonatal period) in this
study was because of reluctancy to medical consultation
by some parents living in rural areas who have low
socioeconomic status. The seven patients who presented
after 1 year had abdominal CLs with late presentation. All
reviews have reported that presentation of CL in
adulthood is rare [11,13].
An antenatal diagnosis was made in seven (7.5%)
patients. This low rate of diagnosis is because of in the
lack of antenatal care in remote, rural areas.
The primary indications for a surgical intervention in the
patients of the series were esthetic reasons, and compres-
sion on airway and digestive systems. We did not encounter
other indications for an urgent intervention such as sudden
enlargement with respiratory compromise [37].
A surgical approach was favored in this series over
injection sclerotherapy; although it is gaining popularity
in the west [32], surgery is still the first line of
management in the developing countries [20].
Surgery for CLs is difficult and may have to be multistage
to remove the lesion. We decided on a multistage
operative approach for 37 cases (all of them were in the
cervical and axillary regions). This is in agreement with
other authors [2] who have used this approach to avoid
injury to vital structures in the neck and axilla.
Although spontaneous regression has been observed by
some authors and thus required conservative manage-
ment, particularly for macrocytic lymphangiomas located
in the posterior triangle of the neck [3,38], we operated
on all patients without awaiting spontaneous regression.
We used the sclerotherapy approach as the primary line
for treatment in four patients and as management for
recurrence in five patients. Evacuation of most of the
fluid out of the lesion is a crucial step for success, as it
facilitates more contact between the sclerosant and the
endothelial lining of the lymphangioma. The amount
injected must not distend the lesion markedly as this may
precipitate inflammation. The total dose of injection
must not exceed 10 mg per injection setting; otherwise,
there may be a risk of development of pulmonary
interstitial fibrosis, a well-documented complication for
this sclerosant [32]. To report the results of sclerotherapy,
we used the criteria for response on the basis of previous
reports to classify results into excellent, good, and poor
responses [39,40].
Fig. 11
Recurrent cervical cystic lymphangioma.
Table 3 Sites of recurrence




Abdominal wall 1 (6.25)
Thigh 1 (6.25)
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Recurrence was the most common complication (17.2%)
in our study. Recurrence after CL excision is high because
of the infiltrative nature of the lesion and the involve-
ment of vital structures, making its complete elimination
very difficult in B60% of cases [41]. The remaining small
lymphatics expand and form the lesion again. In this
respect, our results are in agreement with those of other
reports in the literature [39].
Although we used a nerve stimulator to identify the
related nerves during dissection of the anomaly, we had
two cases of a hypoglossal nerve and one facial nerve
palsy, which indicates that nerve injury may occur despite
efforts to prevent this.
The rate of development of other complications (seroma,
hematoma, unsightly scar, wound disruption) was similar
to that of other reports in the literature [28].
Conclusion
CL has a variable presentation in children. A staged
operative procedure may be necessary in order to reduce
mortality and morbidity including the risk of injury to the
neighboring structures. Sclerotherapy has almost the
same efficacy as the first line of management as surgery,
although it is not widely practiced in developing
countries.
There is a high postoperative complication associated
with surgical excision, especially with head and neck CLs.
Anesthesia in these patients requires careful monitoring.
Long-term follow-up is desirable after excision because of
the possibility of recurrence.
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